Blood Markers Study for Heart Disease and Blood Clot Risk
Part of Heart & circulation clinical trials.
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Hospitalized with heart disease symptoms and need long-term blood thinner medication
- Diagnosed with either acute heart attack or stable heart disease treated with heart stent (PCI)
- Clinically stable and ready for hospital discharge after treatment
- Willing to provide blood samples and participate in follow-up visits
- No serious life-threatening conditions expected in the next 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ways to improve safety for people with high bleeding risk who take blood thinners after getting a heart stent. It aims to find better quality checks to prevent bleeding and clotting problems.
This study looks at how “blood marker” results relate to how well direct oral blood thinners (NOACs) and ticagrelor work, and how likely bleeding might be. If you take these medicines for heart or clot conditions, the trial may help doctors better predict your bleeding risk.
This study checks how well current risk models predict bleeding or clotting events in people with coronary heart disease who take long-term blood thinners. The goal is to help doctors choose the safest treatment plan for you.
This trial looks at two blood test results in people who have had a heart attack or unstable angina. It aims to see if these markers can help doctors understand the severity of the condition.
This study looks at blood “biomarkers” (signals in blood tests) in people who arrive with symptoms that could be a heart attack. It may help doctors spot and manage acute heart problems sooner and more accurately.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.